|
|
|
|
| LEADER |
00000cam a2200000 a 4500 |
| 001 |
SCIDIR_ocn967393718 |
| 003 |
OCoLC |
| 005 |
20231120112203.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
161230s2017 enk ob 001 0 eng d |
| 040 |
|
|
|a IDEBK
|b eng
|e pn
|c IDEBK
|d EBLCP
|d IDEBK
|d OPELS
|d YDX
|d N$T
|d OCLCF
|d NLE
|d OCLCQ
|d UPM
|d OCLCQ
|d OCLCA
|d CASUM
|d OCLCO
|d OTZ
|d MERER
|d OCLCO
|d OCLCQ
|d OCLCO
|d CHVBK
|d OCLCO
|d OCLCQ
|d D6H
|d U3W
|d OCLCQ
|d UKMGB
|d CNCGM
|d OCLCQ
|d OCLCO
|d S2H
|d OCLCO
|d OCLCA
|d OCLCO
|d OCLCQ
|d SFB
|d OCLCO
|
| 015 |
|
|
|a GBB715315
|2 bnb
|
| 016 |
7 |
|
|a 018161898
|2 Uk
|
| 019 |
|
|
|a 967254553
|a 968341581
|
| 020 |
|
|
|a 0128041757
|q (ebk)
|
| 020 |
|
|
|a 9780128041758
|
| 020 |
|
|
|z 9780128041529
|
| 020 |
|
|
|z 0128041528
|
| 035 |
|
|
|a (OCoLC)967393718
|z (OCoLC)967254553
|z (OCoLC)968341581
|
| 050 |
|
4 |
|a RC641.7.A6
|
| 060 |
|
4 |
|a 2017 C-814
|
| 060 |
|
4 |
|a WH 380
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.1/52
|2 23
|
| 245 |
0 |
0 |
|a Congenital and acquired bone marrow failure /
|c edited by M.D. Aljurf, E. Gluckman, C. Dufour.
|
| 260 |
|
|
|a London :
|b Academic Press,
|c 2017.
|
| 300 |
|
|
|a 1 online resource (290)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Cover; Title page; Copyright page; Contents; List of Contributors; Introduction; Chapter 1 -- Epidemiology of Acquired Bone Marrow Failure; Introduction; Incidence of AA in different geographical regions and race; Age and gender related demographics of AA; Posthepatitis AA and AA occurring after viral infections; AA and association with toxins/drugs; AA and association with HLA genes; AA and autoimmune disorders; AA during pregnancy; AA postvaccination; Problems with epidemiological studies in AA and future strategies; References; Chapter 2 -- Pathophysiology of Acquired Bone Marrow Failure.
|
| 505 |
8 |
|
|a Introduction: Evidence and Inferences from the ClinicPathophysiology; Hematopoiesis in AA; Immune Mechanisms in AA; Clinical Data; T Cells and Cytokines; HLA and Cytokine Gene Polymorphisms; Immune Escape Clones (PNH, 6pLOH); STAT3 Mutant Clones; Innate Immunity; microRNAs; Autoantibodies; Immune-Mediated BM Failure Mouse Models; Mouse Models of Chemical and Drug Hematopoietic Toxicity; Genetic Risk Factors in AA; Clonal Evolution in AA; Treatments for AA; BMT With Matched Sibling Donors; BMT From Alternative Donors; Experimental HSCT; IST; Eltrombopag; Supportive Care; Conclusions.
|
| 505 |
8 |
|
|a AA and HLA-DR TypingAA and LGL; Diagnostic of AA in the Elderly; Defining Severity of AA; Defining Response After Treatment; Future challenges in the diagnostics of AA; Acknowledgment; References; Chapter 4 -- Acquired Overlap Bone Marrow Failure Disorders; Introduction; Hypoplastic MDS; Single lineage cytopenias (pure red cell aplasia or immune thrombocytopenia); T cell large granular lymphocytes; Paroxysmal nocturnal hemoglobinuria; Congenital marrow failure undiagnosed; Conclusions; References; Chapter 5 -- Supportive Care in Aplastic Anemia; Introduction.
|
| 505 |
8 |
|
|a Prevention of infections by general medical management of aplastic anemia patientsProtective Environment; Protective Isolation; Special Low Bacterial Diet; Individual Hygiene Rules; Prevention of infections by antibiotic/antimycotic/antiviral prophylaxis; Antimycotic Prophylaxis; Antibiotic Prophylaxis; Antiviral Prophylaxis; Vaccination; Hematopoietic growth factors as prophylaxis of infections or in combination with immunosuppression to improve quality of re ... ; Treatment of infections; Granulocyte Transfusions; Transfusion therapy; Iron chelation therapy; Physical exercise.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
|
0 |
|a Bone marrow
|x Diseases.
|
| 650 |
|
2 |
|a Bone Marrow Diseases
|0 (DNLM)D001855
|
| 650 |
|
6 |
|a Moelle osseuse
|x Maladies.
|0 (CaQQLa)201-0015076
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Bone marrow
|x Diseases
|2 fast
|0 (OCoLC)fst00835945
|
| 655 |
|
0 |
|a Electronic books.
|
| 655 |
|
4 |
|a Internet Resources.
|
| 700 |
1 |
|
|a Gluckman, Eliane.
|
| 700 |
1 |
|
|a Dufour, C.
|
| 700 |
1 |
|
|a Aljurf, Mahmoud Deeb.
|
| 776 |
0 |
8 |
|i Print version:
|z 0128041528
|z 9780128041529
|w (OCoLC)957680589
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780128041529
|z Texto completo
|
